Neuronal targeting in diabetes mellitus: A story of sensory neurons and motor neurons

Neuroscientist

Volumn 14, Issue 4, 2008, Pages 311-318

  Zochodne, D W ^a   Ramji, N ^a   Toth, C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diabetic polyneuropathy; Motor axons; Neurodegeneration

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE DURATION; ELECTROMYOGRAM; MOTONEURON; MUSCLE ACTION POTENTIAL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HUMANS; MOTOR NEURONS; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS, AFFERENT;

EID: 47549101404     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858408316175     Document Type: Review

References (29)

1. Andersen H., Gjerstad MD, Jakobsen J. 2004. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 27: 2382-5.
2. Bril V. 2001. Invited review: status of current clinical trials in diabetic polyneuropathy. Can J Neurol Sci 28: 191-8.
3. Bril V., Werb MR, Greene DA, Sima Aaf. 1996. Single-fiber electromyography in diabetic peripheral polyneuropathy. Muscle Nerve 19: 2-9.
4. Brown MJ, Asbury AK 1984. Diabetic neuropathy. Ann Neurol 15: 2-12.
5. Brussee V., Cunningham FA, Zochodne DW 2004. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes 53: 1824-30. Capes S., Anand S. 2001. What is type 2 diabetes? In: Gerstein HC, Haynes RB, editors. Evidence-based diabetes care. Hamilton (ON): BC Decker. p 151-63.
6. Cheng C., Zochodne DW 2003. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52: 2363-71.
7. Court FA, Alvarez J. 2005. Local regulation of the axonal phenotype, a case of merotrophism. Biol Res 38: 365-74.
8. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R., Pach JM, and others. 1993. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993 ; 43: 817-24.
9. Hossain P., Sachdev A., Malik RA 2005. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 366: 1340-3.
10. Kamiya H., Zhangm W., Sima AA 2005. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats. Diabetes 54: 3288-95.
11. Kennedy JM, Zochodne DW 2005. Experimental diabetic neuropathy and spontaneous recovery: is there irreparable damage ? Diabetes 54: 830-7.
12. McComas AJ, Fawcett PRW, Campbell MJ, Sica REP. 1971. Electrophysiological estimation of the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry 34: 121-31.
13. Mulder DW, Lambert EH, Bastron JA, et al. 1961. The neuropathies associated with diabetes mellitus. Neurology 11: 275-84.
14. Ramji N., Toth C., Kennedy J., Zochodne DW 2007. Does diabetes mellitus target motor neurons ? Neurobiol Dis 26: 301-11.
15. Rundles RW 1945. Diabetic neuropathy-general review with report of 125 cases. Medicine 24: 111-60.
16. Scott JN, Clark AW, Zochodne DW 1999. Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain 122: 2109-18.
17. Sugimoto K., Murakawa Y., Sima AA 2002. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst 7: 44-53.
18. Toth C., Brussee V., Martinez JA, McDonald D., Cunningham FA, Zochodne DW 2006 a. Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience 139: 429-49.
19. Toth C., Brussee V., Zochodne DW 2006 b. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 49: 1081-8.
20. Toth C., Rong LL, Yang C., Martinez J., Song F., Ramji N., Brussee V., Liu W., Durand J., Nguyen MD, Schmidt AM, Zochodne DW 2008. Recptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 57: 1002-1017 ; doi: 10.2337/db07-0339.
21. Toth C., Schmidt AM, Tuor UI, Francis G., Foniok T., Brussee V., and others. 2006 c. Diabetes, leukoencephalopathy and rage: Neurobiol Dis 23: 445-61.
22. van Minnen J., Bergman JJ, Van Kesteren ER, Smit AB, Geraerts WP, Lukowiak K., and others. 1997. De novo protein synthesis in isolated axons of identified neurons. Neuroscience 80: 1-7.
23. Wild S., Roglic G., Green A., Sicree R., King H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-53.
24. Willis D., Li KW, Zheng J-Q., Chang JH, Smit A., Kelly T., and others. 2005. Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J Neurosci 25: 778-91.
25. Xu QG, Li X-Q., Kotecha SA, Cheng C., Sun HS, Zochodne DW 2004. Insulin as an in vivo growth factor. Exp Neurol 188: 43-51.
26. Yagihashi S., Kamijo M., Watanabe K. 1990. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. Am J Pathol 136: 1365-73.
27. Zochodne DW 1999. Diabetic neuropathies: features and mechanisms. Brain Pathol 9: 369-91.
28. Zochodne DW 2002. Nerve and ganglion blood flow in diabetes: an appraisal. In: Tomlinson D, editor. Neurobiology of diabetic neuropathy. San Diego: Academic Press, International Review of Neurobiology, p 161-202.
29. Zochodne DW, Verge VMK, Cheng C., Sun H., Johnston J. 2001. Does diabetes target ganglion neurons? Progressive sensory neuron involvement in long term experimental diabetes. Brain 124: 2319-34.